Related Experiment Videos
Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients
Reza Nosratabadi1, M K Arababadi, G Hassanshahi
1Department of Laboratory Sciences, Faculty of Medicine, Islamic Azad University, Zahedan Branch, Zahedan, Iran.
Abstract:
The present study was aimed to examine the serum level of IFN-gamma in type 2 diabetic patients with nephropatic complications. In this experimental study, serum samples were obtained from 100 type 2 diabetic patients suffering from nephropathy and 100 healthy controls. Serum level of IFN-gamma was analyzed by ELISA. Results of this study showed that the mean serum level of IFN-gamma was 16.09 +/- 2.04 and 4.03 +/- 1.00 pg mL(-1) in nephropathic patients and healthy controls, respectively. Statistical analysis of data showed that the difference in the IFN-gamma serum level was significant between nephropathic patients and controls. Due to the elevated level of IFN-gamma in nephropathic patients, it can be possibly concluded that IFN-gamma is involved in nephropathy complication of type 2 diabetes.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Nephropathy
Nephrotic Syndrome III : Nursing Management
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Nephrotic Syndrome I : Introduction